Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,410.00
-70.00 (-1.08%)
At close: Apr 28, 2026
-11.25%
Market Cap 56.58B
Revenue (ttm) 77.09B
Net Income (ttm) 731.98M
Shares Out 8.83M
EPS (ttm) 55.00
PE Ratio 116.55
Forward PE n/a
Dividend 95.47 (1.47%)
Ex-Dividend Date Dec 29, 2025
Volume 26,780
Average Volume 63,360
Open 6,480.00
Previous Close 6,480.00
Day's Range 6,300.00 - 6,480.00
52-Week Range 5,800.00 - 9,226.11
Beta 0.80
RSI 54.13
Earnings Date Apr 3, 2026

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

In 2025, Seoulin Bioscience's revenue was 77.09 billion, an increase of 2.23% compared to the previous year's 75.41 billion. Earnings were 731.98 million, a decrease of -74.88%.

Financial Statements

News

There is no news available yet.